FDA Drug Application (204683) for KHEDEZLA by OSMOTICA PHARM CORP

Back to FDA Applications sponsored by OSMOTICA PHARM CORP

Application Number204683
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage50MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code BC Extended-release dosage forms (capsules, injectables and tablets)
Reference Drug
Drug NameKHEDEZLA
Active IngredientDESVENLAFAXINE

Active IngredientCount
List of drugs with Active Ingredient DESVENLAFAXINE2


Back to FDA Applications sponsored by OSMOTICA PHARM CORP